Identifying risk factors for severe COVID-19 in patients with AML, MDS and ALL

COVID 19 Focus on High Risk MDS and Secondary AML PatientsПодробнее

COVID-19 risk factors in patients with hematologic malignanciesПодробнее

How likely is it for patients with MDS to transform to AML?Подробнее

Predicting outcomes for patients with leukemia and MDS after COVID-19 infectionПодробнее

The COVID-19 pandemic emergency and management of acute leukemia: challenges and optionsПодробнее

Pre-MDS states: identifying patients at risk and using modern tools to improve prognosisПодробнее

How does COVID-19 affect outcomes in AML?Подробнее

COVID-19 vaccination in MDS & AMLПодробнее

Asaff Harel, MD: Risk Factors for Severe COVID-19 Infection in Multiple SclerosisПодробнее

MDS & COVID-19 VaccineПодробнее

How likely is it for patients with MDS to transform to AML?Подробнее

COVID 19 and Cancer - What You Need to Know NowПодробнее

MPN Transformation to MDS and AML: Risk factors, therapy and outcomesПодробнее

Responses to COVID-19 vaccines in patients with AML and MDSПодробнее

Do genetic tests on suspected MDS cases identify familial mutations that can cause these diseases?Подробнее

Prognostic Factors in Acute Myeloid LeukemiaПодробнее

MPN Transformation to MDS and AML: Risk Factors, Therapy, and OutcomesПодробнее

Responses to COVID-19 vaccination in patients with MDS and AMLПодробнее

COVID-19-related risk factors in patients with blood cancersПодробнее